Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-059954)

Filing Details

Accession Number:: 0001209191-19-059954
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-10 20:07:22
Reporting Period:: 2019-12-06

Accepted Time:: 2019-12-10 20:07:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708493	Harpoon Therapeutics Inc.	HARP	Biological Products, (No Disgnostic Substances) (2836)	473458693

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1734389	Mark Chin	C/O Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA 94080		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-06	47,752	$19.15	2,844,367	No	4	S	Indirect	By Arix Bioscience Holdings Limited
Common Stock	Disposition	2019-12-09	26,438	$18.30	2,817,929	No	4	S	Indirect	By Arix Bioscience Holdings Limited
Common Stock	Disposition	2019-12-09	77,316	$18.12	2,740,613	No	4	S	Indirect	By Arix Bioscience Holdings Limited
Common Stock	Disposition	2019-12-10	131,696	$16.91	2,608,917	No	4	S	Indirect	By Arix Bioscience Holdings Limited

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Arix Bioscience Holdings Limited
No	4	S	Indirect	By Arix Bioscience Holdings Limited
No	4	S	Indirect	By Arix Bioscience Holdings Limited
No	4	S	Indirect	By Arix Bioscience Holdings Limited

Footnotes

The Reporting Person is an Investment Director for Arix Bioscience plc, the parent company of Arix Bioscience Holdings Limited.